17th Dec 2009 07:00
Issued by Citigate Dewe Rogerson Ltd, Birmingham
Date: Thursday, 17 December 2009
Dechra® Pharmaceuticals PLC
("Dechra" or the "Company")
Board Appointment
Non-Executive Director
Dechra is pleased to announce the appointment of Bryan Morton as a Non-Executive Director with effect from 7 January 2010.
Bryan has a 30 year career in the pharmaceutical industry, largely with Merck & Co. Inc. and Bristol Myers Squibb where he has held positions of responsibility within marketing, sales, business development and general management.
In 2003 Bryan founded Zeneus Pharma, an oncology and critical care bio-pharmaceutical company which was sold in 2005. Bryan is currently President and Chief Executive Officer of EUSA Pharma, a specialist pharmaceutical company focussing on oncology, pain control and critical care, which he founded in 2006.
Dechra's Chairman, Michael Redmond, said "The Board is delighted that Bryan has accepted the position of Non-Executive Director and we look forward to working with him to further strengthen Dechra's reputation as a leading international veterinary pharmaceutical business."
There are no other matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.
|
Enquiries: |
|
|
Ian Page, Chief Executive |
Fiona Tooley, Director |
|
Dechra Pharmaceuticals PLC |
Citigate Dewe Rogerson |
|
Tel: +44 (0)1782 771100 |
Tel: +44 (0)121 362 4035 |
|
Mobile: 07775 642222 (IP) |
Mobile: 07785 703523 (FMT) |
|
www.dechra.com |
|
Trademarks appear throughout this release in italics. Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.
Related Shares:
DPH.L